Menu
Back to User profile » Mr William Montgomery
Papers published by Mr William Montgomery:
Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
Montgomery W, Goren A, Kahle-Wrobleski K, Nakamura T, Ueda K
Neuropsychiatric Disease and Treatment 2018, 14:1843-1854
Published Date: 16 July 2018
Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL
Neuropsychiatric Disease and Treatment 2018, 14:611-621
Published Date: 22 February 2018
Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan
Montgomery W, Ueda K, Jorgensen M, Stathis S, Cheng Y, Nakamura T
ClinicoEconomics and Outcomes Research 2018, 10:13-28
Published Date: 28 December 2017
Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
Novick D, Montgomery W, Vorstenbosch E, Moneta MV, Dueñas H, Haro JM
Patient Preference and Adherence 2017, 11:1859-1868
Published Date: 31 October 2017
The economic and humanistic costs of chronic lower back pain in Japan
Montgomery W, Sato M, Nagasaka Y, Vietri J
ClinicoEconomics and Outcomes Research 2017, 9:361-371
Published Date: 23 June 2017
Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM
Patient Preference and Adherence 2017, 11:1019-1025
Published Date: 6 June 2017
Sex differences in the course of schizophrenia across diverse regions of the world
Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM
Neuropsychiatric Disease and Treatment 2016, 12:2927-2939
Published Date: 14 November 2016
The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database
Hung YN, Kadziola Z, Brnabic AJM, Yeh JF, Fuh JL, Hwang JP, Montgomery W
ClinicoEconomics and Outcomes Research 2016, 8:387-395
Published Date: 2 August 2016
The relationship between pain severity and patient-reported outcomes among patients with chronic low back pain in Japan
Montgomery W, Vietri J, Shi J, Ogawa K, Kariyasu S, Alev L, Nakamura M
Journal of Pain Research 2016, 9:337-344
Published Date: 2 June 2016
Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
Treuer T, Méndez L, Montgomery W, Wu S
Neuropsychiatric Disease and Treatment 2016, 12:1061-1083
Published Date: 3 May 2016
Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
Zhang L, Chen Y, Yue L, Liu Q, Montgomery W, Zhi L, Wang W
Neuropsychiatric Disease and Treatment 2016, 12:941-949
Published Date: 20 April 2016
Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
Novick D, Montgomery W, Aguado J, Peng XM, Haro JM
Neuropsychiatric Disease and Treatment 2016, 12:795-800
Published Date: 11 April 2016
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R
Neuropsychiatric Disease and Treatment 2016, 12:383-392
Published Date: 23 February 2016
Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM
Patient Preference and Adherence 2015, 9:1481-1490
Published Date: 16 October 2015
Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
Ogawa K, Fujikoshi S, Montgomery W, Alev L
Neuropsychiatric Disease and Treatment 2015, 11:2101-2107
Published Date: 18 August 2015
Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
Wu J, He XN, Liu L, Ye W, Montgomery W, Xue HB, McCombs JS
Neuropsychiatric Disease and Treatment 2015, 11:983-990
Published Date: 7 April 2015
Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey
Vietri J, Otsubo T, Montgomery W, Tsuji T, Harada E
Neuropsychiatric Disease and Treatment 2015, 11:675-683
Published Date: 13 March 2015
Antidepressant medication treatment patterns in Asian patients with major depressive disorder
Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM
Patient Preference and Adherence 2015, 9:421-428
Published Date: 11 March 2015
Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study
Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM
Neuropsychiatric Disease and Treatment 2015, 11:197-205
Published Date: 22 January 2015
Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
Montgomery W, Kadziola Z, Ye W, Xue HB, Liu L, Treuer T
Neuropsychiatric Disease and Treatment 2015, 11:177-183
Published Date: 19 January 2015
Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study
Song Y, Yang Y, Chen W, Liu W, Wang K, Li X, Wang K, Papadimitropoulos M, Montgomery W
ClinicoEconomics and Outcomes Research 2014, 6:451-461
Published Date: 17 October 2014
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
Ye W, Montgomery W, Kadziola Z, Liu L, Xue H, Stensland MD, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:869-878
Published Date: 16 May 2014
Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
Xue HBH, Liu L, Zhang H, Montgomery W, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:841-864
Published Date: 16 May 2014
Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties
Zhao J, Ou J, Xue H, Liu L, Montgomery W, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:355-359
Published Date: 19 February 2014
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM
Patient Preference and Adherence 2013, 7:987-995
Published Date: 30 September 2013
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H
ClinicoEconomics and Outcomes Research 2013, 5:407-418
Published Date: 14 August 2013
Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM
Patient Preference and Adherence 2013, 7:463-470
Published Date: 27 May 2013
Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence
Kelin K, Lambert TJR, Brnabic AJM, Newton R, Ye W, Escamilla RI, Chen KP, Don L, Montgomery W, Karagianis J, Ascher-Svanum H
Patient Preference and Adherence 2011, 5:213-222
Published Date: 9 May 2011